Home - Medical Policies - Florida
Draft Hemophilia Drug Policies
Drug policies are based on:
- Information in FDA-approved package inserts (and black box warnings, alerts or other information disseminated by the FDA, as applicable);
- Research of current medical and pharmacy literature; and/or,
- Review of common medical practices in the treatment and diagnosis of disease.
Final and draft policies are published on this site. Draft policies are available for provider review for 45 days from the posting date on the policy.
Note: Coverage is subject to member's specific benefits. Group-specific policies will supersede these policies, when applicable. Always verify member eligibility and benefits.
Use the navigation on the left or the search function above to locate specific drug policy information.
Pharmacy drug policies provide a guide to coverage. Pharmacy policies are not intended to dictate to providers how to practice medicine. Providers should exercise their medical judgment in providing the care they feel is most appropriate for their patients.
|Policy #||Policy Title||Print View|
|PH-00340||Hemophilia Products - Factor VIII Prior Authorization Program Summary|